The nucleic acid extraction instruments and reagents market size is projected to surpass around US$ 5 billion by 2030 from US$ 2.5 Bn in 2020.
Increase in R&D funding in healthcare and biotechnology, and rise in technological advancements in molecular testing are expected to drive the nucleic acid extraction instruments & reagents market during the forecast period. Additionally, an increase in the prevalence of infectious diseases, such as COVID-19, is expected to drive the global nucleic acid extraction instruments & reagents market.
The expansion of the nucleic acid extraction instruments & reagents market can be attributed to the rising prevalence of chronic and infectious diseases, increasing number of patients suffering from COVID-19, rise in awareness and acceptance of personalized medicine and companion diagnostics, and increasing geriatric population.
High Demand for Rapid Molecular Diagnosis in Limited Resource Setting to Bolster Market Growth
The uptake of nucleic acid-based diagnostic tests has increased at a noteworthy pace over the past few years and the trend is set to continue during the forecast period. Moreover, as sample preparation from plant and human specimens is predominantly time consuming and involves a number of steps, a well-equipped laboratory and skilled personnel is required. However, to carry out rapid molecular diagnosis in a limited resource setting, nucleic-acid extraction procedures are required to enhance the frequency of field detection without major human intervention– a factor that is expected to fuel the demand for nucleic acid extraction instruments & reagents in the upcoming months.
Recent advancements in point-of-care nucleic acid extraction technologies, and the increasing applicability and robustness of such procedures, especially for the isolation of nucleic acid from raw samples are anticipated to aid the growth of the global nucleic acid extraction instruments & reagents market. Furthermore, the increasing integration of rapid nucleic acid preparation techniques with sensor technologies and various assays is likely to play a key role in revolutionizing the diagnosis of plant and human diseases, particularly in remote and limited resource settings.
In terms of type, the extraction kits, reagents, & consumables segment is projected to account for a major share of the global nucleic acid extraction instruments & reagents market during the forecast period. Nucleic acid extraction kits are commonly used in the clinical microbiology laboratory. These test kits provide essential requirements for nucleic acid extraction. This is likely to drive the segment during the forecast period. Higher usage of nucleic acid extraction kits, reagents, & consumables further boost the segment.
Based on extraction type, the global nucleic acid extraction instruments & reagents market has been classified into DNA extraction, RNA extraction, and DNA/RNA extraction.
In terms of method, the global nucleic acid extraction instruments & reagents market has been segregated into solution-based methods and solid-phase based methods.
Based on end user, the global nucleic acid extraction instruments & reagents market has been split into academic research institutes, hospitals & diagnostics centers, pharmaceutical & biotechnology industry, contract research organizations (CROs), and others.
In terms of revenue, North America was a major market for nucleic acid extraction instruments & reagents in 2020. The growth of the market in the region can be attributed to an increase in the demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides for the treatment of cancer, neurological diseases, and chronic kidney diseases. Moreover, rise in the prevalence of lifestyle diseases, increase in healthcare spending, and strong economy are estimated to contribute to North America’s dominance of the global nucleic acid extraction instruments & reagents market during the forecast period. These factors are likely to augment the market in North America during the forecast period.
The nucleic acid extraction instruments & reagents market in Asia Pacific is likely to expand at a high CAGR from 2020 to 2030 driven by developing countries such as China and India. Increase in population in the large markets of China and India, rise in average life expectancy, and emergence of a new consumptive middle class with higher demands for healthcare are key factors driving more discoveries of newer products, thereby boosting the demand for pharmaceutical and diagnostic products.
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2017 to 2019.
The analysts have provided a comprehensive analysis of the competitive landscape of the global nucleic acid extraction instruments and reagents market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation expected to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users) and other segments.
Key players operating in the global nucleic acid extraction instruments & reagents market are Thermo Fisher Scientific, Inc., Agilent Technologies, Bio-Rad Laboratories, Inc., Merck KGaA, Danaher Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Takara Bio, Inc., Promega Corporation, and QIAGEN.
By Extraction Type
By End User
This report focuses on nucleic acid extraction instruments and reagents market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2030 at the global level, regional level and company level. From a global perspective, this report represents overall nucleic acid extraction instruments and reagents market size by analyzing historical data and future prospect. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics. The study includes drivers and restraints of the global nucleic acid extraction instruments and reagents market.
The research not only conducts forecasts in terms of value, but also evaluates the market on the basis of essential parameters, such as Year-on-Year (Y-o-Y) growth. This helps providers to recognize the future opportunities as well predictability of the market.
In order to understand and assess opportunities in this market, the report is categorically divided into five key sections on the basis of segments. The report analyzes the global market in terms of value (US$ dollers) and volume (Million Units).
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2017 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global nucleic acid extraction instruments and reagents market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the nucleic acid extraction instruments and reagents market.
The report includes country-wise and region-wise market size for the period 2017-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2017-2030.
In this study, the years considered to estimate the market size of nucleic acid extraction instruments and reagents are as follows:
The research methodology adopted by analysts for compiling the global nucleic acid extraction instruments and reagents market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global nucleic acid extraction instruments and reagents market.
The study objectives of this report are:
Omics-based Clinical Trials Market (By Product: Phase I, Phase II, Phase III, Phase IV; By Study Design: Interventional Studies, Observational Studies, Expanded Access Studies; By Indication : Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases, etc)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Complementary and Alternative Medicine for Anti Aging & Longevity Market (By Intervention : Traditional Alternative Medicine/Botanicals, Body Healing, Mind Healing, External Energy Healing, Sensory Healing; By Customer: High Net Worth (HNW) Individuals, Very High Net Worth (VHNW) Individuals, Ultra-high Net Worth (UHNW) Individuals) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Defibrillator Market (By Product: Implantable Cardioverter Defibrillators (ICD), External Defibrillators (ED); By End-use: Hospital, Pre Hospital, Public Access Market, Alternate Care Market, Home Healthcare) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Medical Fiber Optics Market (By Fiber Type: Single Mode Optical Fiber, Multimode Optical Fiber; By Application: Endoscopic Imaging, Laser Signal Delivery, Biomedical Sensing, Illumination) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Pharmacovigilance Market (By Service Provider: In-house, Contract Outsourcing; By Product Life Cycle: Pre-clinical, Phase I, Phase II, Phase III, Phase IV; By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining; By Process Flow: Case Data Management, Signal Detection, Risk Management System) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...